FROM OUR BLOG

Duet Raises $15M; Nvidia Scandal Rattles AI Markets

Duet secures $15M for NP-owned clinics, Ardent buys Boone Health, as Nvidia's CEO exit shakes AI stocks and oil faces a 2027 surplus.

November 16, 2026

This week in brief

  • Healthcare Practice & Business Deals: Two specific transactions stand out this week — a small-clinic growth round and a regional hospital acquisition.
  • Global Markets & Macro: Markets face a volatile stretch as AI leadership uncertainty, oil price pressure, and high-stakes geopolitics converge.

Healthcare Practice & Business Deals

Two specific transactions stand out this week — a small-clinic growth round and a regional hospital acquisition.

Duet scores $15M to expand NP-owned clinic network. Duet closed a $15 million Series A round to grow its network of nurse practitioner-owned clinics. Kairos led the round, with Lerer Hippeau also participating. The raise signals continued private investor appetite for independent, clinician-owned primary care models operating outside traditional health-system structures.

Ardent Health acquires Boone Health for $47M. Ardent Health agreed to acquire Boone Health, a Missouri nonprofit, for $47 million in cash. The deal also includes a 10-year, $200 million capital commitment to the system. Ardent expects the acquisition to generate at least $30 million in annual EBITDA by its third year of ownership. Boone Health reported roughly $500 million in annual revenue, making this a notable regional add-on for Ardent’s growing portfolio.

Beyond these two deals, this week’s healthcare news was dominated by policy and product announcements — including a Medicaid work-requirement enforcement delay and a new Medicare enrollment ban on home health and hospice providers — rather than small-to-medium practice transactions.

Global Markets & Macro

Markets face a volatile stretch as AI leadership uncertainty, oil price pressure, and high-stakes geopolitics converge.

Nvidia CEO resignation rattles AI trade. Jensen Huang resigned as Nvidia CEO following disclosures of an affair and reports linking him to a Chinese intelligence plot. CFO Colette Kress was named interim CEO. Nvidia fell roughly 4% in pre-market trading. CoreWeave dropped approximately 8%. Analysts warn that a more cautious successor could weaken Nvidia’s practice of financially backstopping large AI infrastructure projects — a key pillar of the broader AI buildout. Some economists warn the departure could trigger a wider pullback in AI investment.

AI bubble concerns intensify. Investor confidence in AI valuations was already under pressure before the Nvidia news. Reports indicate OpenAI secured less cash and a lower valuation than expected in a recent funding round. Spending across the sector is outpacing projected returns. Meanwhile, Anthropic’s market debut is expected shortly, drawing close attention from traders watching whether demand holds for high-valuation AI names.

Tech stocks slide ahead of Nvidia earnings week. US tech stocks opened lower as traders cut risk ahead of Nvidia’s scheduled earnings report and Anthropic’s anticipated IPO. European stocks held roughly steady. The selloff reflected broad caution rather than a single catalyst. The broader market backdrop remains one where the ten largest IPOs of 2026 have fallen more than 20% on average, according to Financial Times data.

Goldman warns of a sizable 2027 oil surplus. Goldman Sachs projected a “sizable surplus” in the oil market next year. The firm expects Brent crude futures to average $88 per barrel in 2027, easing to $78 by year-end as risk premiums normalize. Oil prices declined this week amid signs that the physical barrel market is well supplied. Meanwhile, European natural gas dipped as record US export flows offset concerns about thin winter storage on the continent.

Geopolitics add to market uncertainty. High-stakes diplomacy in Asia — involving leaders of the US, China, and Russia — kept investors cautious. Ukraine struck the Crimean Bridge in what Russia’s defense ministry described as the largest drone attack since the war began. Separately, the European Union is preparing a €45 billion loan for Ukraine, to be borrowed against the EU budget and presented to member states this week. The rand weakened toward 17 per dollar as South Africa’s coalition government faced fresh political pressure, compounded by expectations of a Federal Reserve rate hike next month.

What to Watch

Nvidia’s earnings report and Anthropic’s expected market debut will set the tone for AI sentiment in the days ahead. Any further leadership instability at Nvidia — or disappointing guidance — could accelerate the rotation away from high-multiple tech names. On the healthcare deal front, rising employer health costs and tightening Medicare enrollment rules for home health and hospice may push more independent operators toward an earlier-than-planned exit. Watch whether Ardent-style regional acquisitions pick up pace as smaller systems feel margin pressure. The Fed’s rate path, still signaling a possible December hike, will remain a key variable for deal financing across both sectors.


Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.

What do these market moves mean for your practice value?

Get a confidential read on what your practice is worth in today's market.

Request a confidential review

About Tenet Mergers & Acquisitions

Tenet Mergers & Acquisitions is a sell-side advisory firm for healthcare practice owners exploring a sale, partnership or transition.

Meet the team

THINKING ABOUT SELLING YOUR MEDICAL PRACTICE?

Get a confidential practice valuation.

If you’re considering selling your practice — or exploring your options — a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

START THE CONVERSATION

If you’re considering a sale, exploring acquisitions or planning ahead,
we’re here to help.

Schedule a confidential consultation to learn how our services can support your goals.